Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

The Effect of Psychological Distress and Personality Traits on Cognitive Performances and the Risk of Dementia in Patients with Mild Cognitive Impairment.

Ramakers IH, Honings ST, Ponds RW, Aalten P, Köhler S, Verhey FR, Visser PJ.

J Alzheimers Dis. 2015 Apr 8. [Epub ahead of print]

PMID:
25854926
2.

Boosting translational research on Alzheimer's disease in Europe: The Innovative Medicine Initiative AD research platform.

Vaudano E, Vannieuwenhuyse B, Van Der Geyten S, van der Lei J, Visser PJ, Streffer J, Ritchie C, McHale D, Lovestone S, Hofmann-Apitius M, Truyen L, Goldman M.

Alzheimers Dement. 2015 Apr 6. pii: S1552-5260(15)00057-6. doi: 10.1016/j.jalz.2015.02.002. [Epub ahead of print] No abstract available.

PMID:
25754460
3.

Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.

Vos SJ, Verhey F, Frölich L, Kornhuber J, Wiltfang J, Maier W, Peters O, Rüther E, Nobili F, Morbelli S, Frisoni GB, Drzezga A, Didic M, van Berckel BN, Simmons A, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Lovestone S, Muscio C, Herukka SK, Salmon E, Bastin C, Wallin A, Nordlund A, de Mendonça A, Silva D, Santana I, Lemos R, Engelborghs S, Van der Mussele S; The Alzheimer’s Disease Neuroimaging Initiative, Freund-Levi Y, Wallin ÅK, Hampel H, van der Flier W, Scheltens P, Visser PJ.

Brain. 2015 Feb 17. pii: awv029. [Epub ahead of print]

PMID:
25693589
4.

The influence of genetic variants in SORL1 gene on the manifestation of Alzheimer's disease.

Louwersheimer E, Ramirez A, Cruchaga C, Becker T, Kornhuber J, Peters O, Heilmann S, Wiltfang J, Jessen F, Visser PJ, Scheltens P, Pijnenburg YA, Teunissen CE, Barkhof F, van Swieten JC, Holstege H, Van der Flier WM; Alzheimer's Disease Neuroimaging Initiative and Dementia Competence Network.

Neurobiol Aging. 2015 Mar;36(3):1605.e13-20. doi: 10.1016/j.neurobiolaging.2014.12.007. Epub 2014 Dec 11.

PMID:
25659857
5.

Amyloid-β Oligomers Relate to Cognitive Decline in Alzheimer's Disease.

Jongbloed W, Bruggink KA, Kester MI, Visser PJ, Scheltens P, Blankenstein MA, Verbeek MM, Teunissen CE, Veerhuis R.

J Alzheimers Dis. 2015 Jan 1;45(1):35-43. doi: 10.3233/JAD-142136.

PMID:
25547634
6.

Predicting progression from cognitive impairment to Alzheimer's disease with the Disease State Index.

Hall A, Mattila J, Koikkalainen J, Lötjonen J, Wolz R, Scheltens P, Frisoni G, Tsolaki M, Nobili F, Freund-Levi Y, Minthon L, Frölich L, Hampel H, Visser PJ, Soininen H.

Curr Alzheimer Res. 2015;12(1):69-79.

PMID:
25523428
7.

Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases.

Lleó A, Cavedo E, Parnetti L, Vanderstichele H, Herukka SK, Andreasen N, Ghidoni R, Lewczuk P, Jeromin A, Winblad B, Tsolaki M, Mroczko B, Visser PJ, Santana I, Svenningsson P, Blennow K, Aarsland D, Molinuevo JL, Zetterberg H, Mollenhauer B.

Nat Rev Neurol. 2015 Jan;11(1):41-55. doi: 10.1038/nrneurol.2014.232. Epub 2014 Dec 16.

PMID:
25511894
8.

The trajectory of cognitive decline in the pre-dementia phase in memory clinic visitors: findings from the 4C-MCI study.

Hamel R, Köhler S, Sistermans N, Koene T, Pijnenburg Y, van der Flier W, Scheltens P, Aalten P, Verhey F, Visser PJ, Ramakers I.

Psychol Med. 2015 May;45(7):1509-19. doi: 10.1017/S0033291714002645. Epub 2014 Nov 19.

PMID:
25407094
9.

Generalizability of the disease state index prediction model for identifying patients progressing from mild cognitive impairment to Alzheimer's disease.

Hall A, Muñoz-Ruiz M, Mattila J, Koikkalainen J, Tsolaki M, Mecocci P, Kloszewska I, Vellas B, Lovestone S, Visser PJ, Lötjonen J, Soininen H; Alzheimer Disease Neuroimaging Initiative; AddNeuroMed consortium; DESCRIPA and Kuopio L-MCI.

J Alzheimers Dis. 2015;44(1):79-92. doi: 10.3233/JAD-140942.

PMID:
25201784
10.

The use of biomarkers for the etiologic diagnosis of MCI in Europe: An EADC survey.

Bocchetta M, Galluzzi S, Kehoe PG, Aguera E, Bernabei R, Bullock R, Ceccaldi M, Dartigues JF, de Mendonça A, Didic M, Eriksdotter M, Félician O, Frölich L, Gertz HJ, Hallikainen M, Hasselbalch SG, Hausner L, Heuser I, Jessen F, Jones RW, Kurz A, Lawlor B, Lleo A, Martinez-Lage P, Mecocci P, Mehrabian S, Monsch A, Nobili F, Nordberg A, Rikkert MO, Orgogozo JM, Pasquier F, Peters O, Salmon E, Sánchez-Castellano C, Santana I, Sarazin M, Traykov L, Tsolaki M, Visser PJ, Wallin ÅK, Wilcock G, Wilkinson D, Wolf H, Yener G, Zekry D, Frisoni GB.

Alzheimers Dement. 2015 Feb;11(2):195-206.e1. doi: 10.1016/j.jalz.2014.06.006. Epub 2014 Aug 20.

PMID:
25150733
11.

Temporal evolution of biomarkers and cognitive markers in the asymptomatic, MCI, and dementia stage of Alzheimer's disease.

Bertens D, Knol DL, Scheltens P, Visser PJ; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2014 Aug 20. pii: S1552-5260(14)02462-5. doi: 10.1016/j.jalz.2014.05.1754. [Epub ahead of print]

PMID:
25150730
12.

Variability of CSF Alzheimer's disease biomarkers: implications for clinical practice.

Vos SJ, Visser PJ, Verhey F, Aalten P, Knol D, Ramakers I, Scheltens P, Rikkert MG, Verbeek MM, Teunissen CE.

PLoS One. 2014 Jun 24;9(6):e100784. doi: 10.1371/journal.pone.0100784. eCollection 2014.

13.

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.

Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, DeKosky ST, Gauthier S, Selkoe D, Bateman R, Cappa S, Crutch S, Engelborghs S, Frisoni GB, Fox NC, Galasko D, Habert MO, Jicha GA, Nordberg A, Pasquier F, Rabinovici G, Robert P, Rowe C, Salloway S, Sarazin M, Epelbaum S, de Souza LC, Vellas B, Visser PJ, Schneider L, Stern Y, Scheltens P, Cummings JL.

Lancet Neurol. 2014 Jun;13(6):614-29. doi: 10.1016/S1474-4422(14)70090-0. Erratum in: Lancet Neurol. 2014 Aug;13(8):757.

PMID:
24849862
14.

A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease.

Jessen F, Amariglio RE, van Boxtel M, Breteler M, Ceccaldi M, Chételat G, Dubois B, Dufouil C, Ellis KA, van der Flier WM, Glodzik L, van Harten AC, de Leon MJ, McHugh P, Mielke MM, Molinuevo JL, Mosconi L, Osorio RS, Perrotin A, Petersen RC, Rabin LA, Rami L, Reisberg B, Rentz DM, Sachdev PS, de la Sayette V, Saykin AJ, Scheltens P, Shulman MB, Slavin MJ, Sperling RA, Stewart R, Uspenskaya O, Vellas B, Visser PJ, Wagner M; Subjective Cognitive Decline Initiative (SCD-I) Working Group.

Alzheimers Dement. 2014 Nov;10(6):844-52. doi: 10.1016/j.jalz.2014.01.001. Epub 2014 May 3.

PMID:
24798886
15.

The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?

Duits FH, Teunissen CE, Bouwman FH, Visser PJ, Mattsson N, Zetterberg H, Blennow K, Hansson O, Minthon L, Andreasen N, Marcusson J, Wallin A, Rikkert MO, Tsolaki M, Parnetti L, Herukka SK, Hampel H, De Leon MJ, Schröder J, Aarsland D, Blankenstein MA, Scheltens P, van der Flier WM.

Alzheimers Dement. 2014 Nov;10(6):713-723.e2. doi: 10.1016/j.jalz.2013.12.023. Epub 2014 Apr 8.

PMID:
24721526
16.

Optimizing patient care and research: the Amsterdam Dementia Cohort.

van der Flier WM, Pijnenburg YA, Prins N, Lemstra AW, Bouwman FH, Teunissen CE, van Berckel BN, Stam CJ, Barkhof F, Visser PJ, van Egmond E, Scheltens P.

J Alzheimers Dis. 2014;41(1):313-27. doi: 10.3233/JAD-132306.

PMID:
24614907
17.

Evidence of a nonequilibrium distribution of quasiparticles in the microwave response of a superconducting aluminum resonator.

de Visser PJ, Goldie DJ, Diener P, Withington S, Baselmans JJ, Klapwijk TM.

Phys Rev Lett. 2014 Jan 31;112(4):047004. Epub 2014 Jan 28.

PMID:
24580483
18.

Hippocampal volume change measurement: quantitative assessment of the reproducibility of expert manual outlining and the automated methods FreeSurfer and FIRST.

Mulder ER, de Jong RA, Knol DL, van Schijndel RA, Cover KS, Visser PJ, Barkhof F, Vrenken H; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2014 May 15;92:169-81. doi: 10.1016/j.neuroimage.2014.01.058. Epub 2014 Feb 9.

PMID:
24521851
19.

Fluctuations in the electron system of a superconductor exposed to a photon flux.

de Visser PJ, Baselmans JJ, Bueno J, Llombart N, Klapwijk TM.

Nat Commun. 2014;5:3130. doi: 10.1038/ncomms4130.

20.

Preclinical AD predicts decline in memory and executive functions in subjective complaints.

van Harten AC, Smits LL, Teunissen CE, Visser PJ, Koene T, Blankenstein MA, Scheltens P, van der Flier WM.

Neurology. 2013 Oct 15;81(16):1409-16. doi: 10.1212/WNL.0b013e3182a8418b. Epub 2013 Sep 18.

PMID:
24049134
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk